Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175

Journal of Ocular Pharmacology and Therapeutics

Volumn 13, Issue 6, 1997, Pages 517-528

  Neuenschwander, Heike ^a   Takahashi, Yukio ^a   Kador, Peter F ^a,b  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLSORBINIL; ALDOSE REDUCTASE INHIBITOR; GALACTOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIET; DOG; DOSE RESPONSE; IMAGE ANALYSIS; MALE; MICROANEURYSM; NONHUMAN; ORAL DRUG ADMINISTRATION; PERICYTE; RETINA BLOOD VESSEL;

EID: 0031440825     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1997.13.517     Document Type: Article

References (29)

1. Ferris, F.L. III. Diabetic retinopathy. Diabetes Care 16(suppl 1):322-325, 1993.
2. Kuwabara, T. and Cogan, D.G. Studies of retinal vascular patterns. Part I. Normal Architecture. Arch. Ophthalmol. 64:904-911, 1960.
3. Cogan, D.G. and Kuwabara, T. The mural cell in perspective. Arch. Ophthalmol. 78:133-139, 1967.
4. Chan, L.S., Li, W., Khatami, M. and Rockey, J.H. Actin in cultured retinal capillary pericytes: morphological and functional correlations. Exp. Eye Res. 43:41-54, 1987.
5. Orlidge, A. and D'Amore, P.A. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105:1455-1462, 1987.
6. Antonelli-Orlidge, A., Saunders, K.B., Smith, S.R. and D'Amore, P.A. An activated form of transforming growth factor beta is produced by co-cultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86:4544-4548, 1989.
7. Akagi, Y., Kador, P.F., Kuwabara, T. and Kinoshita, J.H. Aldose reductase localization in human retinal mural cells. Invest. Ophthalmol. Vis. Sci. 24:1516-19, 1983.
8. Akagi, Y., Terubayashi, H., Millen, J., Kador, P.F. and Kinoshita, J.H. Aldose reductase localization in dog retinal mural cells. Curr. Eye Res. 5:883-886, 1986.
9. Hohman, T.C., Nishimura, C. and Robison, W.G. Jr. Aldose reductase and polyol in cultured pericytes of human retinal capillaries. Exp. Eye Res. 48:55-60, 1989.
10. Kador, P.F., Sato, S., Neuenschwander, H., Lizak, M.J., Secchi, E.F., Greentree, W. and Takahashi, Y. Recent studies on the polyol pathway: The relationship between aldose reductase catalyzed polyol production, retinopathy and sorbitol dehydrogenase. Recent studies on the polyol pathway: In Diabetes 1994. S. Baba and T. Kaneko, eds. Elsevier, Amsterdam, NL, 1995, p. 315-320.
11. Patz, A. and Maumenee, A.E. Studies on diabetic retinopathy. I. Retinopathy in a dog with spontaneous diabetes mellitus. Am. J. Ophthalmol. 54:532-541, 1962.
12. Hausler, H.R., Sibay, T.M. and Campbell, J. Retinopathy in a dog following diabetes induced by growth hormone. Diabetes 13:122-126, 1964.
13. Engerman, R.L. and Bloodworth, J.M.B. Jr. Experimental diabetic retinopathy in dogs. Arch. Ophthalmol. 73:205-210, 1965.
14. Engerman, R.L. and Kern, T.S. Experimental galactosemia produces diabetic-like retinopathy. Diabetes 33:97-100, 1984
15. Kador, P. F., Akagi, Y., Terubayashi, H., Wyman, M. and Kinoshita, J.H. Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors. Arch. Ophthalmol. 106:1099-1102, 1988.
16. Takahashi, Y., Wyman, M., Ferris F. and Kador, P.F. Diabeteslike preproliferative retinal changes in galactose-fed dogs. Arch. Ophthalmol. 110:1295-1302, 1992.
17. Kador, P.F., Takahashi, Y., Wyman, M. and Ferris, F. III Diabeteslike proliferative retinal changes in galactose-fed dogs. Arch. Ophthalmol. 113:352-354, 1995.
18. Kador, P.F., Akagi, Y., Takahashi, Y., Ikebe, H., Wyman, M. and Kinoshita J.H. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch. Ophthalmol. 108:1301-1309, 1990.
19. Takahashi, Y., Augustin, W., Wyman, M. and Kador P.F. Quantitative analysis of retinal vessel changes in galactose-fed dogs. J. Ocul. Pharmacol. 9:257-269, 1993.
20. Kador, P.F. Prevention of ocular diabetic complications by aldose reductase inhibitors. Swiss Pharma 12:33-38, 1990.
21. Kador, P.F., Takahashi, Y., Sato, S. and Wyman, M. Amelioration of diabetes-like retinal changes in galactose-fed dogs. Preventive Med 23:717-721, 1994.
22. Sato, S., Takahashi, Y., Wyman, M. and Kador, P.F. Progression of sugar cataract in the dog. Invest. Ophthalmol. Vis. Sci. 32:1925-1931, 1991.
23. Sorbinil Retinopathy Trial Research Group. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch. Ophthalmol. 108:1234-1244, 1990.
24. Kador, P.F., Terubayashi, H., Wyman, M. and Kinoshita, J.H. The role of aldose reductase in retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs. In Proceedings of a Workshop on Aldose Reductase Inhibitors Sponsored by the National Eye Institute and Juvenile Diabetes Foundation on September 4-5, 1990. NIH Publication No. 91-3114, 1991, p. 75-88.
25. Kern, T. Dog model for diabetic retinopathy and nephropathy. In Proceedings of a Workshop on Aldose Reductase Inhibitors Sponsored by the National Eye Institute and Juvenile Diabetes Foundation on September 4-5, 1990. NIH Publication No. 91-3114, 1991 p. 65-73.
26. Engerman, R.L. and Kern, T.S. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes 42:820-825, 1993.
27. Kador, P.F. and Kinoshita, J.H. Diabetic and galactosemic cataracts. Ciba Foundation Symposium No 106, Human Cataract Formation, 110-123, 1984.
28. Robison, W.G. Jr. and Laver, N. Ocular lesions in animal models of human diabetes. In Lessons from Animal Diabetes IV. E. Shafrir, ed., Smith Gordon, Great Britain, 1993, p. 145-163.
29. Robison, W.G. Jr., Kador, P.F. and Kinoshita, J.H. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science 221:1177-1179, 1983.